Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02692898 · ClinicalTrials.gov registry record
Biomarker Analysis of Central Nervous System Tumors
A clinical trial, sponsored by National Cancer Institute (NCI).
- Terminated
- Registry status
- 12
- Enrollment target
NCT02692898: Clinical Trial study, sponsored by National Cancer Institute (NCI).
NCT02692898 is a clinical trial that was terminated before completion, run by National Cancer Institute (NCI). The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02692898 was terminated before completion, sponsored by National Cancer Institute (NCI).
- TERMINATED
- Registry status
- 12 participants
- Enrollment target
Study Summary
Background: The number of people who get tumors of the brain or central nervous system (CNS) is lower than other cancers. But these tumors cause a higher rate of serious effects and even death. Researchers want to test existing samples of tissue from these tumors to learn more about them. This may lead to better treatment. Objective: To study stored samples of CNS tumors to learn more about the tumors and explore new ways to diagnose them. Eligibility: The study will use tissue samples already collected at NIH from people with brain or CNS tumors. Design: The participants will have given their consent in a previous study. Researchers will review the tissue samples and any data collected about them. Researchers will do lab tests and scans on the samples. All data will be kept secure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2016-02-25 |
| Est. Completion | 2019-11-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02692898
The ClinicalTrials.gov registry entry for NCT02692898 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02692898 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02692898 about?
NCT02692898 is a clinical study titled "Biomarker Analysis of Central Nervous System Tumors". Background: The number of people who get tumors of the brain or central nervous system (CNS) is lower than other cancers. But these tumors cause a higher rate of serious effects and even death. Researchers want to test existing samples of tissue from these tumors to learn more about them. This may ...
What is the current status of trial NCT02692898?
This trial is currently terminated. The enrollment target is 12 participants. The study started on 2016-02-25. Estimated completion is 2019-11-15.
Who is sponsoring clinical trial NCT02692898?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.